Ranking Invest

Caris Life Sciences, Inc.

Segmento: Healthcare Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.

Indicadores Básicos

Valor de Mercado

$ 10.27 Bi

IVR

0.08

IVR2

0.03

Índices de Previsibilidade

Faturamento

0.11

Lucro

0.64

Margem

0.64

Índices de Tendência

Faturamento

-6.61

Lucro

2.44

Margem

3.68

Índices de Endividamento

DIV/PAT

2.76

DIV/L4T

15.91

Dívida Líquida

$ 2.21 Bi

Patrimônio Líquido

$ 800.72 Mi

L4T

$ 139.08 Mi

MM4T

40.35%

Dívidas
Dividendos
Cotação: $36.93

Não há dados de histórico de dividendos para exibir.

Gráfico Lucro/Faturamento X Trimestre